DK0539575T3 - Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner. - Google Patents

Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner.

Info

Publication number
DK0539575T3
DK0539575T3 DK92913637.2T DK92913637T DK0539575T3 DK 0539575 T3 DK0539575 T3 DK 0539575T3 DK 92913637 T DK92913637 T DK 92913637T DK 0539575 T3 DK0539575 T3 DK 0539575T3
Authority
DK
Denmark
Prior art keywords
ones
metastasis
pyridyloxasol
inhibition
cancer patients
Prior art date
Application number
DK92913637.2T
Other languages
English (en)
Inventor
Alan J Bitonti
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0539575T3 publication Critical patent/DK0539575T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK92913637.2T 1991-05-14 1992-04-14 Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner. DK0539575T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69982191A 1991-05-14 1991-05-14

Publications (1)

Publication Number Publication Date
DK0539575T3 true DK0539575T3 (da) 1997-10-27

Family

ID=24811050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92913637.2T DK0539575T3 (da) 1991-05-14 1992-04-14 Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner.

Country Status (12)

Country Link
US (1) US5610171A (da)
EP (1) EP0539575B1 (da)
AT (1) ATE155686T1 (da)
AU (1) AU645217B2 (da)
CA (1) CA2087334A1 (da)
DE (1) DE69221069T2 (da)
DK (1) DK0539575T3 (da)
ES (1) ES2106874T3 (da)
GR (1) GR3024832T3 (da)
IE (1) IE921524A1 (da)
NZ (1) NZ242677A (da)
WO (1) WO1992020337A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070009529A1 (en) * 2002-03-26 2007-01-11 New York University Agents that dissolve arterial thrombi
US8753631B2 (en) * 2009-05-01 2014-06-17 New York University Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935902A1 (de) * 1979-09-05 1981-04-02 A. Nattermann & Cie GmbH, 5000 Köln Oxazolinalkansaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
ZA908852B (en) * 1989-11-13 1991-09-25 Merrell Dow Pharma Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones
US5182293A (en) * 1989-11-13 1993-01-26 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones

Also Published As

Publication number Publication date
GR3024832T3 (en) 1998-01-30
AU2167692A (en) 1992-12-30
IE921524A1 (en) 1992-11-18
EP0539575B1 (en) 1997-07-23
WO1992020337A2 (en) 1992-11-26
CA2087334A1 (en) 1992-11-15
ES2106874T3 (es) 1997-11-16
EP0539575A1 (en) 1993-05-05
NZ242677A (en) 1997-06-24
DE69221069T2 (de) 1997-11-13
ATE155686T1 (de) 1997-08-15
AU645217B2 (en) 1994-01-06
DE69221069D1 (de) 1997-08-28
US5610171A (en) 1997-03-11
WO1992020337A3 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
ATE164593T1 (de) Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
MY125587A (en) Protien kinase c inhibitors.
ATE155143T1 (de) 2-substituierte indan-2-mercaptoacetylamid- verbindungen mit enkephalinase und ace- hemmwirkung
ATE364592T1 (de) Tyrosinderivate
DK0705100T3 (da) Terapeutiske substituerede guanidiner
FI941519A (fi) Farnesyyliproteiinitransferaasin heterosyklisiä inhibiittoreita
ATE143972T1 (de) 2-substituierte indane-2-carboxyalkyl- verbindungen mit enkephalinase und ace- hemmwirkung
NO20010053L (no) Farnesyl proteintransferaseinhibitorer for behandling av artropatier
DK0610317T3 (da) Inhibitorer af dipeptidyl-aminopeptidase type IV
ATE353320T1 (de) Tricyclische proteinkinasehemmer
TR199900048T2 (xx) Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler
FI962246A0 (fi) Apoptoosia inhiboivat koostumukset, koostumusten puhdistusmenetelmät ja niiden käyttö
DE69413815T2 (de) Inhibierung des Haarwuchses
DE69427756T2 (de) Hemmung des haarwachstum
DE69220382D1 (de) Verwendung von Peptidderivaten
ATE242234T1 (de) Bicyclische arylcarboxamide und ihre therapeutische verwendung
KR950700412A (ko) 종양성장을 저해시키는 단백질 성분물(protein compound capable of inhibiting tumoral growth)
DE69231390D1 (de) Anisotropische Ablagerung von Dielektrika
TR199700392A2 (xx) Kronik-fibrogenetik karaci�er hastal�klar�n�n, akut karaci�er hastal�klar�n�n ve bunlara ba�l� komplikasyonlar�n tedavi edilmesi ve �nlenmesi i�in peptik olmayan bradikinin antagonistlerinin kullan�lmas�.
DK0530937T3 (da) Inhibitor med collagenfremkaldt blodpladeaggregering
DK0539575T3 (da) Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner.
ITTO930549A0 (it) Trattamento superficiale di refrattari
ATE247088T1 (de) Peptidverbindungen mit mmp- und tnf-hemmender wirkung
BR9106506A (pt) Sequencia de nucleotideos do gene de estearoila-acp dessaturase de soja
ITMI910661U1 (it) Porta-libretto di assegni con mezzi anticontraffazione degli assegni